Investors with a lot of money to spend have taken a bullish stance on G1 Therapeutics GTHX.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GTHX, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 10 uncommon options trades for G1 Therapeutics.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 40%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $721,794, and 4 are calls, for a total amount of $202,882.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $5.0 and $7.5 for G1 Therapeutics, spanning the last three months.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for G1 Therapeutics's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across G1 Therapeutics's significant trades, within a strike price range of $5.0 to $7.5, over the past month.
G1 Therapeutics Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| GTHX | PUT | TRADE | BEARISH | 04/19/24 | $5.00 | $375.0K | 342 | 1.5K |
| GTHX | PUT | SWEEP | BULLISH | 04/19/24 | $5.00 | $117.7K | 342 | 1.5K |
| GTHX | CALL | SWEEP | BULLISH | 04/19/24 | $5.00 | $102.4K | 13.3K | 500 |
| GTHX | PUT | SWEEP | BEARISH | 04/19/24 | $5.00 | $99.4K | 342 | 3.3K |
| GTHX | PUT | SWEEP | BULLISH | 04/19/24 | $5.00 | $62.5K | 342 | 2.3K |
About G1 Therapeutics
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat the types of cancer, such as cell lung cancer and breast cancer, and designs them to combine - and enhance - the anti-tumor activity of current therapies.
Having examined the options trading patterns of G1 Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Current Position of G1 Therapeutics
- With a trading volume of 868,989, the price of GTHX is up by 1.32%, reaching $4.59.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 16 days from now.
Expert Opinions on G1 Therapeutics
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $14.0.
- An analyst from Needham downgraded its action to Buy with a price target of $14.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for G1 Therapeutics with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
